Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational Smokers

View source ↗

Summary

This clinical trial update describes quantifying human cerebral nicotinic receptors using the PET tracer 2-[18F]FA-85380 in healthy non-smokers, ex-smokers, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-[18F]FA-85380 (2-[18F]FA-85380)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Nicotine Addiction | Status: COMPLETED